Éva Bozó

599 total citations
35 papers, 416 citations indexed

About

Éva Bozó is a scholar working on Organic Chemistry, Molecular Biology and Social Psychology. According to data from OpenAlex, Éva Bozó has authored 35 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 17 papers in Molecular Biology and 5 papers in Social Psychology. Recurrent topics in Éva Bozó's work include Carbohydrate Chemistry and Synthesis (19 papers), Glycosylation and Glycoproteins Research (10 papers) and Neuroendocrine regulation and behavior (5 papers). Éva Bozó is often cited by papers focused on Carbohydrate Chemistry and Synthesis (19 papers), Glycosylation and Glycoproteins Research (10 papers) and Neuroendocrine regulation and behavior (5 papers). Éva Bozó collaborates with scholars based in Hungary and Switzerland. Éva Bozó's co-authors include János Kuszmann, Sándor Boros, Andrea Vasella, Bruno Bernet, Eszter Gács‐Baitz, László Pa̋rkányi, György M. Keserű, Sándor Farkas, Sándor Kolok and György Domány and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Carbohydrate Research.

In The Last Decade

Éva Bozó

34 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éva Bozó Hungary 13 334 225 37 33 26 35 416
Alberto A. Ghini Argentina 13 260 0.8× 242 1.1× 40 1.1× 31 0.9× 19 0.7× 36 538
Darryl H. Steensma United States 8 355 1.1× 368 1.6× 34 0.9× 27 0.8× 36 1.4× 12 489
François Crestey Denmark 13 290 0.9× 184 0.8× 21 0.6× 34 1.0× 10 0.4× 27 404
V. John Jasys United States 10 186 0.6× 206 0.9× 58 1.6× 41 1.2× 24 0.9× 16 390
Claudia Bonaccini Italy 13 236 0.7× 411 1.8× 52 1.4× 57 1.7× 31 1.2× 17 627
Karin Briner United States 14 489 1.5× 370 1.6× 38 1.0× 37 1.1× 12 0.5× 28 650
Iván Collado Spain 13 289 0.9× 259 1.2× 86 2.3× 21 0.6× 50 1.9× 17 447
Daniele Andreotti Italy 13 291 0.9× 190 0.8× 31 0.8× 47 1.4× 17 0.7× 34 507
Rishi G. Vaswani United States 11 240 0.7× 179 0.8× 35 0.9× 20 0.6× 16 0.6× 12 388
Isabelle Parrot France 12 250 0.7× 220 1.0× 35 0.9× 37 1.1× 15 0.6× 26 384

Countries citing papers authored by Éva Bozó

Since Specialization
Citations

This map shows the geographic impact of Éva Bozó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éva Bozó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éva Bozó more than expected).

Fields of papers citing papers by Éva Bozó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éva Bozó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éva Bozó. The network helps show where Éva Bozó may publish in the future.

Co-authorship network of co-authors of Éva Bozó

This figure shows the co-authorship network connecting the top 25 collaborators of Éva Bozó. A scholar is included among the top collaborators of Éva Bozó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éva Bozó. Éva Bozó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baska, Ferenc, et al.. (2023). Vasopressin receptor antagonists: a patent summary (2018-2022). Expert Opinion on Therapeutic Patents. 33(5). 385–395. 5 indexed citations
2.
Baska, Ferenc, et al.. (2020). New V1a receptor antagonist. Part 1. Synthesis and SAR development of urea derivatives. Bioorganic & Medicinal Chemistry Letters. 30(18). 127416–127416. 1 indexed citations
3.
Éles, János, Éva Bozó, Ákos Tarcsay, et al.. (2012). Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(9). 3095–3099. 20 indexed citations
4.
Bozó, Éva, János Éles, & György M. Keserű. (2012). Bradykinin B1 receptor antagonists: a patent update 2009 – 2012. Expert Opinion on Therapeutic Patents. 22(12). 1443–1452. 9 indexed citations
5.
Kolok, Sándor, Anikó Gere, Éva Ágai-Csongor, et al.. (2003). Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(21). 3859–3861. 23 indexed citations
6.
Bozó, Éva, et al.. (2002). Synthesis of 4-cyano and 4-nitrophenyl 1,6-dithio-d-manno-, l-ido- and d-glucoseptanosides possessing antithrombotic activity. Carbohydrate Research. 337(15). 1351–1365. 10 indexed citations
7.
Bozó, Éva, et al.. (2002). The behavior of two thiosugar thioglycosides towards oxidation. Tetrahedron Asymmetry. 12(24). 3423–3433. 8 indexed citations
8.
Bozó, Éva, Sándor Boros, & János Kuszmann. (2001). Conversion of 2,6-anhydro-d-altrose and -mannose derivatives with 4-substituted phenyl thiols to prepare compounds with potential antithrombotic activity. Carbohydrate Research. 332(3). 325–333. 4 indexed citations
9.
Bozó, Éva, et al.. (2000). Synthesis of 4-substituted phenyl 2,5-anhydro-1,6-dithio-α- -gluco- and -α- -guloseptanosides possessing antithrombotic activity. Carbohydrate Research. 329(1). 25–40. 15 indexed citations
10.
Bozó, Éva, Sándor Boros, László Pa̋rkányi, & János Kuszmann. (2000). Synthesis of 4-cyano- and 4-nitrophenyl 2,5-anhydro-1,6-dithio-α-d-gluco- and -α-l-guloseptanosides carrying different substituents at C-3 and C-4. Carbohydrate Research. 329(2). 269–286. 8 indexed citations
11.
Bozó, Éva, Sándor Boros, & János Kuszmann. (1999). Synthesis of 4-Cyanophenyl and 4-Nitrophenyl 2,6-Anhydro-1,2-dithio-D-manno-and altropyranosides and Their Derivatives Possessing Antithrombotic Activity. Polish Journal of Chemistry. 73(6). 989–1001. 7 indexed citations
12.
Bozó, Éva, Sándor Boros, & János Kuszmann. (1999). Synthesis of 4-cyanophenyl and 4-nitrophenyl 1,5-dithio-d-ribopyranosides as well as their 2-deoxy and 2,3-dideoxy derivatives possessing antithrombotic activity. Carbohydrate Research. 321(1-2). 52–66. 5 indexed citations
15.
Bozó, Éva, Sándor Boros, & János Kuszmann. (1997). Synthesis of 4-cyanophenyl 1,5-dithio-β-d-glucopyranoside and its 6-deoxy, as well as 6-deoxy-5-ene derivatives as oral antithrombotic agents. Carbohydrate Research. 304(3-4). 271–280. 14 indexed citations
16.
Bozó, Éva, Sándor Boros, & János Kuszmann. (1997). Synthesis of 4-cyanophenyl 2-deoxy-1,5-dithio-β-d-threo-pentopyranoside. Carbohydrate Research. 299(1-2). 59–67. 18 indexed citations
17.
Bozó, Éva, Sándor Boros, & János Kuszmann. (1997). Synthesis of 4-cyanophenyl 4-azido-4-deoxy-1,5-dithio-β-d-xylopyranoside. Carbohydrate Research. 302(3-4). 149–162. 11 indexed citations
18.
Bozó, Éva, Sándor Boros, János Kuszmann, & Eszter Gács‐Baitz. (1996). Synthesis of 6-deoxy-5-thio-d-glucose. Carbohydrate Research. 290(2). 159–173. 15 indexed citations
19.
Bozó, Éva & Andrea Vasella. (1992). Glycosylidene Carbenes. Part 10. Regioselective Glycosidation of 4,6‐O‐Benzylidene‐D‐altropyranosides. Helvetica Chimica Acta. 75(8). 2613–2633. 20 indexed citations
20.
Bozó, Éva, et al.. (1989). 1, 2, 4 ‐ Triazoles, III: New 1,5‐Diaryl‐3‐(substituted amino)‐1H‐1,2,4‐triazoles as Anti‐inflammatory Agents. Archiv der Pharmazie. 322(10). 583–587. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026